Japan Society for the Promotion of Science (JSPS) is the leading research funding agency in Japan, established by the Japanese Government for the purpose of contributing to the advancement of science. Our Summer Programme provides the opportunity pre and post-doctoral researchers to receive an orientation on Japanese culture and research systems and to conduct collaborative research activities with leading research groups at Japanese Universities and research institutions over a period of 2 months during the summer.
Value of award: Return international airfare, maintanence allowance (534,000, JPY), domestic research trip allowance (58,500 JPY) and overseas travel and accident insurance policy are provided.
Eligibility: Applicants need to be a UK national or permanent resident and should be of graduate student status (Master or PhD) or be a recent PhD holder (within the last 6 years) and should be based at a UK university or research institution. Eligible research fields are not limited.
Applications should be sent to the British Council Tokyo. Application guidelines and form are available on their website here: http://www.britishcouncil.org/japan-science-research.htm.
The RKE Operations team can help you with your application. Please direct any enquiries to RKE Ops in the first instance.
Application Deadline: Tuesday, 15th January 2013. Fellowship to take place during fixed period: 11 June to 21 August 2013
Opportunity for Japanese researchers based in the UK










BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease